Published in J Immunol on November 01, 1985
The structure of the human CD2 gene and its expression in transgenic mice. EMBO J (1988) 2.00
Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins. J Exp Med (1992) 1.81
Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues. J Exp Med (1988) 1.62
Molecular cloning of two CD7 (T-cell leukemia antigen) cDNAs by a COS cell expression system. EMBO J (1987) 1.57
Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies. Blood (2015) 1.35
Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia. Am J Pathol (1989) 1.09
Identification of pre-T cells in human peripheral blood. Extrathymic differentiation of CD7+CD3- cells into CD3+ gamma/delta+ or alpha/beta+ T cells. J Exp Med (1989) 1.05
Studies of human bone marrow treated with soybean lectin and sheep erythrocytes: stepwise analysis of cell morphology, phenotype and function. Clin Exp Immunol (1987) 0.85
Identification and cloning of a prethymic precursor T lymphocyte from a population of common acute lymphoblastic leukemia antigen (CALLA)-positive fetal bone marrow cells. J Exp Med (1987) 0.84
Cultured human thymus epithelial monolayer cells induce CD4 expression on mononuclear cells of AIDS patients in vitro. Clin Exp Immunol (1986) 0.75
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell (1984) 6.78
A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature (1982) 5.95
Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature (1984) 4.30
Structural organization of the bcr gene and its role in the Ph' translocation. Nature (1985) 4.08
Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia (1995) 4.04
Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr (1997) 3.80
Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med (2000) 3.70
Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature (1984) 3.24
A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med (1999) 3.11
The gene encoding the epsilon subunit of the T3/T-cell receptor complex maps to chromosome 11 in humans and to chromosome 9 in mice. Proc Natl Acad Sci U S A (1987) 2.91
Production of refractory dissolved organic matter by bacteria. Science (2001) 2.72
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. J Clin Oncol (2001) 2.71
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology (2005) 2.69
The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin Exp Immunol (1981) 2.54
Translocation of oncogene c-sis from chromosome 22 to chromosome 11 in a Ewing sarcoma-derived cell line. Mol Cell Biol (1985) 2.45
Regional mapping of the human immunoglobulin lambda light chain to the Philadelphia chromosome in chronic myeloid leukaemia. Leuk Res (1984) 2.44
Bulk chemical characteristics of dissolved organic matter in the ocean. Science (1992) 2.31
Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes. J Exp Med (1993) 2.23
Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes (1994) 2.17
Effects of cyclosporine on cytokines and cytokine receptors in psoriasis. J Am Acad Dermatol (1995) 2.14
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol (2000) 2.09
Clinical significance of t(14; 18)-positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission. J Clin Oncol (1994) 2.08
In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood (1995) 2.00
E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol Cell (2000) 1.99
Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. Br J Cancer (2009) 1.93
T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med (Berl) (2001) 1.86
Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia. Leukemia (2001) 1.84
Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia (1999) 1.83
Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environ Health Perspect (2000) 1.82
Childhood leukemia and parental occupation. A register-based case-control study. Am J Epidemiol (1985) 1.75
Immunologic effects of background prenatal and postnatal exposure to dioxins and polychlorinated biphenyls in Dutch infants. Pediatr Res (1995) 1.73
The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcript. Mol Cell Biol (1986) 1.72
Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia (1998) 1.68
Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry (2000) 1.66
Antibody formation in mouse bone marrow. I. Evidence for the development of plaque-forming cells in situ. Immunology (1974) 1.65
Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody. J Exp Med (1988) 1.62
Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. N Engl J Med (1985) 1.61
Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques. Leukemia (1999) 1.61
Childhood leukemia and infectious diseases in the first year of life: a register-based case-control study. Am J Epidemiol (1986) 1.60
Genetic factors in congenital diaphragmatic hernia. Am J Hum Genet (2007) 1.58
Unique selection determinant in polyclonal V delta 2-J delta 1 junctional regions of human peripheral gamma delta T lymphocytes. J Immunol (1994) 1.54
Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res (2003) 1.54
Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples. Leukemia (2006) 1.53
Congenital diaphragmatic hernia and chromosome 15q26: determination of a candidate region by use of fluorescent in situ hybridization and array-based comparative genomic hybridization. Am J Hum Genet (2005) 1.52
Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations. Blood (2001) 1.52
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia. Leukemia (2005) 1.50
[Immunology in medical practice. XXXV. Screening of suspected immunodeficiency: diagnostic protocols for patients with opportunistic or recurrent severe infections, wasting and failure to thrive]. Ned Tijdschr Geneeskd (2000) 1.50
The prognosis of oncologic patients in the pediatric intensive care unit. Intensive Care Med (1996) 1.45
[Widely divergent clinical phenotype of x-linked agammaglobulinemia in two cousins]. Ned Tijdschr Geneeskd (2004) 1.44
Minimal residual disease in leukaemia patients. Lancet Oncol (2001) 1.43
Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR. Leukemia (2002) 1.42
Antibody formation in mouse bone marrow. IV. The influence of splenectomy on the bone marrow plaque-forming cell response to sheep red blood cells. Cell Immunol (1975) 1.42
Transfusion of red cells after autologous bone marrow harvest in patients with acute leukemia and malignant lymphoma. Transfusion (1990) 1.40
[Immunology in medical practice. XXI. Laboratory tests for immunologic diseases]. Ned Tijdschr Geneeskd (1999) 1.39
Invasive Aspergillus infection in chronic granulomatous disease: treatment with itraconazole. J Pediatr (1989) 1.39
The mechanism of thymus-dependent antibody formation in bone marrow. J Immunol (1981) 1.37
Isotypes and specificities of immunoglobulins produced by germ-free mice fed chemically defined ultrafiltered "antigen-free" diet. Eur J Immunol (1984) 1.37
Preferential rearrangements of the T cell receptor-delta-deleting elements in human T cells. J Immunol (1997) 1.36
Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. Ann Intern Med (1985) 1.34
Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia (1997) 1.33
Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/c mice fed chemically defined ultrafiltered diet. Eur J Immunol (1989) 1.32
Are maternal fertility problems related to childhood leukaemia? Int J Epidemiol (1985) 1.31
Molecular characterization of the testis specific c-abl mRNA in mouse. EMBO J (1987) 1.31
Specific sequelae after Fontan operation at mid- and long-term follow-up. Arrhythmia, liver dysfunction, and coagulation disorders. J Thorac Cardiovasc Surg (1993) 1.29
Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14. Leukemia (2001) 1.28
Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids. Virology (1989) 1.26
In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. Blood (1990) 1.26
Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Lancet (1991) 1.26
Antibody L26 recognizes an intracellular epitope on the B-cell-associated CD20 antigen. Am J Pathol (1990) 1.26
Obesity after successful treatment of acute lymphoblastic leukemia in childhood. Pediatr Res (1995) 1.24
TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation. Blood (1999) 1.22
Degradation of polysaccharides and lignin by ruminal bacteria and fungi. Appl Environ Microbiol (1988) 1.22
Clones of helper T cells mediate antigen-specific, H-2-restricted DTH. Nature (1981) 1.21
The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur J Immunol (1993) 1.21
Antibody formation in mouse bone marrow. IX. Peripheral lymphoid organs are involved in the initiation of bone marrow antibody formation. Cell Immunol (1977) 1.20
Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia. Blood (1999) 1.20
Causes of death--other than progressive leukemia--in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience. Leukemia (2005) 1.19
c-sis is translocated from chromosome 22 to chromosome 9 in chronic myelocytic leukemia. J Exp Med (1983) 1.19
Point mutations in the beta-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease. Blood (1991) 1.17
Isolation and quantification of dissolved lignin from natural waters using solid-phase extraction and GC/MS. Anal Chem (2000) 1.17
High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol (1996) 1.16
Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL. Leukemia (2002) 1.16
Studies on antibody to intrinsic factor. J Clin Invest (1967) 1.14
Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia (2000) 1.14
Induction of antibodies by Staphylococcus aureus nasal colonization in young children. Clin Microbiol Infect (2009) 1.12
The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells. J Immunol (1991) 1.12
Antibody formation in mouse bone marrow. III. Effects of route of priming and antigen dose. Immunology (1974) 1.12